Edouard Trabulsi is a Genitourinary physician affiliated with Thomas Jefferson University. OpenAlex indexes 439 publications with 8,253 citations (h-index 47); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Urology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology
Sponsor: Molecular Insight Pharmaceuticals, Inc.
- Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
29 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
2 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Multi-modality detection of RCC Recurrence Post Ablation
Thomas Jefferson University
FY2026$583,254R01CA269750 - Multi-modality detection of RCC Recurrence Post Ablation
Thomas Jefferson University
FY2025$589,728R01CA269750 - Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer
Thomas Jefferson University
FY2024$564,183R01CA249921
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
Journal of Clinical Oncology
2025 - Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
International Journal of Radiation Oncology*Biology*Physics
2021 - Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Journal of Clinical Oncology
2020 - Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
Journal of Clinical Oncology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
David Whellan, MD
Thomas Jefferson University
Jesse Roman, MD
Thomas Jefferson University
Stephen Silberstein, MD
Thomas Jefferson University
David Cognetti, MD
Thomas Jefferson University
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”